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presence of serum.15 This in vitro model is unlikely to be
an adequate representation of the regulation of MMP syn-
thesis by monocyte/macrophages in vivo. For example,
not all macrophages in the atherosclerotic plaque express
MMPs,16 despite contact with the extracellular matrix.
Also, various matrix proteins can have differential effects
on MMP synthesis. Shapiro et al17 reported that native
and denatured collagens I and III, but not type IV colla-
gen, fibronectin, laminin, or elastin, stimulated the secre-
tion of MMP1, but not MMP9, by cultured alveolar
macrophages. Therefore, the nature of the matrix mole-
cules in the arterial wall may influence MMP expression in
the monocyte/macrophage.
MMP9, which cleaves basement membrane collagens
type IV and V and gelatin, fibronectin, and elastin,18 is a
major MMP produced by human macrophages. In addi-
tion, the extent of MMP9 synthesis has been correlated
with unstable angina,19 which emphasizes the importance
of understanding the regulation of this MMP.
We studied the regulation in monocyte-derived
macrophages of MMP9 synthesis by extracellular matrix,
growth factors, and cytokines that are found in the ather-
osclerotic plaque. Our data suggest that the physical state
of collagen surrounding macrophages can dramatically
affect the basal level of MMP9 expression and, conse-
quently, responsiveness to growth factors and cytokines.
MATERIALS AND METHODS
Reagents. Cytokines and growth factors were pur-
chased (R&D, Minneapolis, Minn), with the exception of
Several matrix metalloproteinase (MMP) family mem-
bers are expressed in atherosclerotic plaques1-3 and arterial
aneurysms4,5 by the major cell types found in these
pathologies: smooth muscle cells, T-lymphocytes, endothe-
lial cells, and macrophages.6-9 The macrophage appears to
be particularly important, because the relative macrophage
content in an atherosclerotic plaque correlates with the
propensity of the plaque cap to rupture.10 Plaque rupture
is thought to result from the degradation of the cap matrix
by macrophage-derived MMPs.11 Degradation of the
medial extracellular matrix by macrophage-derive MMPs
also can lead to the formation of aneurysms.12-14
Monocyte/macrophage production of MMPs, includ-
ing MMP9, is closely associated with the extent of their
differentiation.8 Freshly isolated monocytes, which pro-
duce primarily serine proteinases, become predominately
MMP-producing cells when cultured on plastic in the
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The production of matrix metalloproteinases (MMPs), such as MMP9, by macrophages may be a critical factor in the
rupture of unstable atherosclerotic plaques and aortic aneurysms. Therefore, we studied the role of matrix and soluble
cytokines in the regulation of monocyte/macrophage expression of MMP9. Although freshly isolated monocytes syn-
thesize little MMP9, cells cultured on tissue-culture plastic differentiate into macrophages and synthesize maximal
amounts of MMP9. Differentiated macrophages cultured on plastic are unresponsive to further stimulation by inter-
leukin 1β, tumor necrosis factor α, or platelet-derived growth factor BB. In contrast, monocytes cultured on polymer-
ized collagen synthesize much less MMP9 than cells cultured on plastic and demonstrate a more than three-fold increase
in MMP9 synthesis in response to interleukin 1β, tumor necrosis factor α, and platelet-derived growth factor BB. To
determine whether the physical state of the collagen was critical for the decrease in basal synthesis of MMP9, mono-
cytes were cultured in suspension for 5 days to allow differentiation and then seeded onto monomer or polymerized
collagen. Synthesis of MMP9 was significantly decreased in cells on polymerized collagen and modestly increased in
macrophages seeded on monomer collagen. These results suggest that MMP9 synthesis by macrophages in the vessel
wall may be under negative control by native, polymerized collagen and that disruption of this native conformation
could increase MMP9 production. In addition, cells in contact with the collagen matrix are potentially more respon-
sive to soluble mediators such as platelet-derived growth factor, interleukin 1β, and tumor necrosis factor α. (J Vasc
Surg 2001;34:1111-8.)
1111
JOURNAL OF VASCULAR SURGERY
December 2001
platelet-derived growth factor (PDGF)-BB and -AA,
which were provided by C. Hart (Zymogenetics, Seattle,
Wash). The collagen preparation used was Vitrogen 100
(Cohesion Technology, Palo Alto, Calif), which is approx-
imately 95% type I collagen and approximately 5% type III
collagen. The monoclonal antibody against CD68 and the
rabbit antibody against CD3 were purchased (Dako,
Carpinteria, Calif). Rabbit antiserum against MMP920 was
a gift from Howard Welgus (Park Davis, Ann Arbor,
Mich). Hydron was obtained from Interferon Sciences
(New Brunswick, NJ). All cell culture supplies were from
Falcon (Beckton Dickenson, Bedford, Mass) and Gibco
(Rockville, Md).
Isolation and culture of human monocytes. Human
monocytes were isolated in two ways, and in each experi-
ment we used cells isolated from a different donor. In the
first procedure (method 1), mononuclear cells were iso-
lated by means of density gradient centrifugation with
Ficol Paque21 and plated at 150,000 cells/cm2 on plastic
culture dishes, on dishes coated with thick gels of fibrillar
collagen (1-2.4 mg/mL, prepared as suggested by the
manufacturer; 0.2 mL/cm2), or on dishes coated with thin
layers of monomer or polymerized collagen. For thin lay-
ers, the plates were preincubated with 100 µg/mL
Vitrogen for 1 hour at 37°C and then washed and stored
in RPMI-1640. For monomer collagen thin layers, the col-
lagen was diluted in 0.1 mol/L acetic acid, which prevents
polymerization of the collagen fibrils. For a polymerized
collagen thin layer, the Vitrogen was brought to pH 7.4
(with 7X RPMI-1640 and NaOH as needed), which pro-
motes polymerization of the collagen fibrils. Cells were
incubated in collagen-coated or uncoated dishes in RPMI-
1640 at 37°C for 2 hours, followed by rinses to remove
non-adherent cells. The cells then were incubated either in
RPMI-1640 with 20% autologous serum or in macrophage
serum-free medium with 10 ng/mL of macrophage colony
stimulating factor (M-CSF). The serum-containing
medium was changed every 3 days, whereas the serum-free
medium with M-CSF was changed after 24 hours and then
every other day.
We used a second procedure (method 2) for isolating
monocytes for suspension culture. These cells were iso-
lated by using Leukoprep tubes as described by Nakano et
al,22 with the additional step of incubating the buffy coat
cells in polypropylene tubes overnight at 4°C before iso-
lating the monocytes. The monocytes were cultured in
10% human plasma-derived serum (prepared as described
earlier23) in RPMI-1640 on plates treated with Hydron
(precoated with 12% Hydron in ethanol for 24 hours at
room temperature and then washed three times with
phosphate-buffered saline [PBS]) to prevent adherence.
The experimental protocol and informed consent were
approved by the University of Washington Institutional
Review Board, and all subjects gave informed consent.
Fig 2. Synthesis of MMP9 by monocytes isolated by method 1
and cultured for 7 days on plastic or polymerized collagen gels
with 50 µCi/mL 35S-methionine for the last 48 hours. *P < .05
versus plastic; †P < .05 versus polymerized collagen, n = 4.Fig 1. A, Gelatin zymography of medium conditioned by mono-
cyte/macrophages. Cells were isolated by method 1 and cultured
on plastic in autologous serum plus or minus 10 ng/mL PMA.
Medium was changed to serum-free medium plus or minus 10
ng/mL PMA at the indicated time and conditioned for 24 hours
before performing zymography. The representative zymogram
shown is consistent with a replicate experiment and published
results.8,15 B, The effect of 10 ng/mL of either PDGF-BB, IL1β,
TNFα, or PMA on MMP9 synthesis by macrophages isolated by
method 1 and cultured on plastic in autologous serum for 7 days
with 50 µCi/mL 35S-methionine for the last 48 hours. MMP9
was radioimmunoprecipitated, quantitated by means of
PhosphorImaging analysis, and expressed as fold of control val-
ues. N = 4-5. *P < .05 versus control.
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Metabolic labeling and immunoprecipitation of
MMP9. Cells were labeled with 50 µCi [35S] methio-
nine/mL (Amersham) for the time indicated for specific
experiments. For example, the cells grown in serum-
containing medium for 7 days were labeled during the last
48 hours of culture with 50 µCi [35S] methionine/mL in
methionine-free RPMI-1640 with 20% dialyzed serum in
the presence or absence of PDGF-BB, PDGF-AA, inter-
leukin 1β (IL1β), or tumor necrosis factor α (TNFα).
Conditioned medium was diluted 1-to-1 with PBS con-
taining 0.8% Triton, 1% bovine serum albumin, 5 mmol/
L ethylenediamine tetraacetic acid, 5 µg/mL aprotinin, 
1 µg/mL pepstatin, and 1 µg/mL leupeptin. The medium
was cleared with Protein-A Sepharose for 10 minutes at
4°C. After centrifugation, the supernatant was incubated
overnight at 4°C with rabbit antiserum against MMP9 or
non-immune rabbit serum (1:2500). Immune complexes
were precipitated with Protein-A Sepharose at 4°C for 45
minutes and washed twice with PBS containing 0.4%
Triton, 5 mmol/L ethylenediamine tetraacetic acid, and
1% bovine serum albumin. After two more washes with
buffer lacking albumin, samples were subjected to sodium
dodecylsulfate-polyacrylamide gel electrophoresis (elec-
trophoresis supplies were from Bio-Rad) under reducing
conditions. Dried gels were analyzed by means of both
autoradiography and PhosphorImager quantitation.
Zymography. Cells isolated by means of method 1
were cultured on plastic in autologous serum plus or
minus 10 ng/mL phorbol myristate acetate. The medium
was changed to serum-free medium plus or minus 10
ng/mL PMA immediately after cell isolation or after 1, 3,
4, or 6 days. The serum-free medium was conditioned for
24 hours before performing gelatin zymography as
described.6 Aliquots of 10 µL of conditioned medium
were tested, and equivalent cell numbers were verified by
means of DNA assay at the end of the experiments.
[I125]Acetyl-low-density lipoprotein degradation.
Acetylated low-density lipoprotein (LDL) was prepared
and iodinated as described earlier.24,25 Cells in triplicate
wells were washed twice and incubated in serum-free
RPMI-1640 with 1, 5, 10, and 25 µg/mL of [125I] acetyl-
LDL for 5 hours. Trichloroacetic acid (TCA) soluble 125I
in the supernatant was determined as described earlier,25
as a measure of cell-mediated uptake and degradation of
[125I] acetyl-LDL.
DNA assay. DNA was quantified as described ear-
lier.26 Cells grown on plastic dishes or on polymerized col-
lagen gels were digested with a solution of 1N NaOH for
Fig 3. Phase-contrast microscopy of human monocyte-derived macrophages cultured 7 days on a thick layer of polymerized collagen or
on plastic with 20% autologous serum (magnification, 200×).
Lepidi et al 1113
JOURNAL OF VASCULAR SURGERY
December 2001
24 to 48 hours at 37°C. After neutralization with HCl,
DNA was precipitated with TCA (6% final) at 4°C. The
pellet was washed with 0.2 mol/L K Acetate in 70%
ethanol, and then 250 µg/mL of 3,5 diaminobenzoic acid
was added for 45 minutes at 55°C. The reaction was
stopped with 1N HCl, and the samples were read with a
fluorimeter set at excitation and emission wavelengths of
350 to 360 nm and 520 nm, respectively. Calf thymus
DNA was used as a standard.
Immunocytochemistry. To characterize the popula-
tion of white blood cells adhering to fibrillar collagen as
compared with those adhering to plastic, we plated the
cells on plastic chamber slides with or without a 1- to 2-
mm layer of fibrillar collagen. After 2 hours of incubation
in RPMI-1640 at 37°C, the non-adherent cells were
washed away with two washes, and the adherent popula-
tion was fixed in 100% methanol for 10 minutes. Cells
were also fixed after 7 days in culture with 20% serum in
RPMI. Slides then were incubated for 1 hour at room
temperature with antibodies against CD68 (1 µg/mL)
and CD3 (1 µg/mL), which are markers for monocytes
and lymphocytes, respectively. Biotinylated secondary
antibodies were used as a means of detection (1:500;
Vector, ABC Elite Kit) with DAB (Sigma) as the chro-
mogen. Cells were counterstained with hemotoxylin, and
the percentage of labeled cells was determined by count-
ing preparations of three different donors.
Microscopy. Cell morphology was assessed by means
of phase-contrast microscopy of live cells and by means of
scanning electron microscopy (SEM) of fixed cells. The
extent of cell spreading, earlier recognized as an indication
of cell differentiation,27 was assessed by means of phase
contrast microscopy with a Nikon phase-contrast micro-
scope. SEM specimens were washed with PBS, fixed in 3%
glutaraldehyde, processed, critical-point dried, sputter-
coated with gold-platinum alloy, and observed with the
JEOL 35C (JEOL, Peabody, Mass).
Statistical analysis. All values presented are the mean
plus or minus the SEM of the number of independent
experiments indicated. Each experiment was performed
with monocytes isolated from a different donor.
Differences between groups were tested with the
Wilcoxon signed rank test (SPSS 8.0 software for
Windows).
RESULTS
To test the effect of extracellular matrix proteins on
MMP9 expression by monocytes, we compared culture of
freshly isolated monocytes on plastic and polymerized col-
lagen gels. Monocytes isolated by means of density gradi-
ent centrifugation on Ficol Paque (method 1) and
cultured on plastic dishes with autologous serum demon-
strated increased MMP9 synthesis compared with freshly
isolated monocytes, starting within 3 days after seeding
and peaking after 6 to 7 days (Fig 1A). The addition of
IL1β, TNFα, or PDGF-BB did not alter the synthesis of
MMP9 (Fig 1B), and phorbol ester had a two-fold stimu-
latory effect. Because monocytes appear to synthesize
maximal levels of MMP9 when cultured on plastic, we
hypothesized that extracellular matrix, unlike plastic, may
normally inhibit basal MMP9 synthesis. Therefore, we
tested the effect of seeding monocytes (prepared by
method 1) on polymerized type I collagen. The cells cul-
tured on collagen gels synthesized about 80-fold less
MMP9 than cells seeded on plastic (Fig 2) and became
much more responsive to phorbol ester (19 ± 3-fold of
control, compared with 2 ± 1-fold of plastic control; n =
5). The number of monocytes and lymphocytes were the
same on polymerized collagen as on plastic after both 2
hours (93% ± 3% monocytes and 6% ± 1% lymphocytes on
polymerized collagen vs 88% ± 3% monocytes and 9% ± 2%
lymphocytes on plastic, n = 3) and 7 days (95% ± 4%
monocytes and 3% ± 2% lymphocytes on polymerized col-
lagen vs 92% ± 4% monocytes and 2% ± 1% lymphocytes
on plastic, n = 3). DNA content at 7 days was also com-
parable (1.14 ± 0.3 µg per 2-cm2 well for polymerized col-
lagen gels and 1.2 ± 0.4 µg for plastic; n = 4). However,
the cells on polymerized collagen remained rounded,
whereas those on plastic spread (Fig 3). Compared with
cells on plastic, cells on polymerized collagen also
degraded less 125I acetylated-LDL (Fig 4) and synthesized
less protein (8.3% ± 0.63% of the amount of TCA precip-
itable 35S-methionine observed with cells cultured on
plastic, n = 3). However, the decrease in MMP9 was more
pronounced than the decrease in protein synthesis (~80-
fold vs ~13-fold reduction for MMP9 vs total protein syn-
thesis). Together, these data suggest that culturing
monocytes on polymerized collagen inhibits monocyte
differentiation.
To determine whether the physical state of the colla-
gen was critical to the inhibitory effect on MMP9 synthe-
Fig 4. Degradation of 125I Acetyl-LDL by monocyte/
macrophages cultured on polymeric collagen (closed circles) or
plastic (open circles) in RPMI and 20% autologous serum for 7
days. Data (mean ± SEM; n = 3) are expressed as a percent of
maximal degradation, which averaged (± SEM) 946 ± 108 ng
125I-AcLDL/24 hours/0.3.106 cells.
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sis, we seeded freshly isolated monocytes (method 1) onto
either monomer collagen or polymerized collagen. Cells
on monomer collagen began spreading within 2 hours,
whereas cells on polymerized collagen remained rounded
(Fig 5A, top and bottom panels, respectively) and never
spread in 7 days (data not shown). The amount of MMP9
synthesized between days 5 and 7 by cells on polymerized
collagen was 11% ± 4% of the value of cells on monomer
collagen (P < .03; n = 6).
To confirm these observations in conditions in which
the differentiation state of the cells would be comparable,
we tested the effects of monomer collagen and polymer-
ized collagen on monocytes allowed to differentiate in
suspension for 5 days in culture dishes coated with
Hydron (method 2). In suspension culture, monocytes
mature into macrophages, showing a doubling in size and
increased phagocytic and lysozyme activity.28 These cells
were harvested and plated on monomer collagen, poly-
merized collagen, or continued in suspension culture.
Although not as dramatic a difference as with cells on
plastic, cells on monomer collagen displayed more
spreading than cells on polymerized collagen (Fig 5B).
Synthesis and secretion of MMP9 in 24 hours by cells on
polymerized collagen was decreased 76% as compared
with cells in suspension, whereas synthesis of MMP9 by
cells on monomer collagen was increased three-fold (Fig
6). MMP9 synthesis by cells on monomer collagen was
inhibited by overlaying the cells with polymerized colla-
gen (5% ± 2% of the value for monomer collagen alone
with a 9-hour labeling period; n = 3). The difference in
thickness of the polymerized collagen gel and the
monomer collagen layer was not a significant factor in the
differences observed between these two collagens,
because a thin layer of polymerized collagen had a com-
parable effect on MMP9 synthesis as a thick gel of poly-
merized collagen (12.4% ± 0.7% and 2.5% ± 1.4% of the
value for monomer collagen, respectively; n = 2). Finally,
inhibition by polymerized collagen could be reversed
with the addition of 10 ng/mL TNFα (Table) or by
means of resuspending the cells with bacterial collagenase
and seeding cells on monomer collagen or plastic (data
not presented), thus demonstrating the viability and
responsiveness of these cells.
Because basal synthesis of MMP9 is decreased on
polymerized collagen, we tested the effect of cytokines on
monocytes seeded onto polymerized collagen gels. We
observed that IL1β, TNFα, and PDGF-BB, but not
PDGF-AA, stimulated the synthesis of MMP9 (Fig 7A).
Pairwise combinations of PDGF-BB, IL1β, and TNFα at
maximally effective doses (10 ng/mL; data not presented)
and the combination of all three factors (Fig 7B) yielded
less than additive effects.
Fig 5. A, Scanning electron micrographs of monocytes isolated
by means of method 2 and seeded on either monomer (top panel)
or polymerized (bottom panel) collagen for 2 hours. The few fila-
ments observed in the monomer preparation are polymerized col-
lagen. The bar indicates 1 micron. B, Phase-contrast microscopy
of monocytes isolated by means of method 2 that were cultured
in suspension on Hydron for 5 days, then seeded onto thin layers
of either monomer or polymerized collagen (phase-contrast at
200×).
A
A
B
Lepidi et al 1115
JOURNAL OF VASCULAR SURGERY
December 2001
DISCUSSION
Native polymerized collagen decreases basal levels
of MMP9 secretion by monocyte-derived macrophages.
Our studies demonstrate that within 3 hours of plating
monocyte-derived macrophages on polymerized collagen
gels, the basal levels of MMP9 secretion are significantly
decreased. The response to polymerized collagen is depen-
dent on the physical characteristics of polymerized collagen,
because monomer type I collagen enhances MMP9 secre-
tion. Adhesion of monocyte-derived macrophages to
monomer collagen type I29 and type IV collagen30 has been
shown to induce expression of MMP9, but the effects of
polymerized collagen fibrils have not been analyzed. The
normal arterial media is composed of a fibrillar meshwork of
extracellular matrix, including polymerized type I collagen
fibrils. In atherogenesis, polymerized collagen fibrils are also
found in well-developed fibrous caps, but are generally
absent from intermediate stages of lesion development and
restenotic tissue that instead contain thin and disordered
collagen fibers31 and collagen fragments32 that may be
more closely modeled by monomer collagen. Thus, our
data suggest that matrix in the normal media and the more
advanced fibrous cap would significantly decrease the basal
expression of MMP9. Analysis of MMP9 localization in ath-
erosclerotic plaques is consistent with this finding,1 because
MMP9 is increased in plaque shoulders and regions of foam
cell accumulation.
Decreased expression of MMP9 by macrophages
on polymerized collagen may be related to altered cell
shape. Earlier studies have demonstrated that induction
of MMP9 in macrophages on monomer collagen paral-
leled the timing and extent of cell adhesion and spread-
ing.33 Blockade of integrins required for spreading of
macrophages on fibronectin and agents, such as colchicine
and cytochalisn D, that inhibit spreading also prevent
MMP9 secretion.29,33 In our studies, monocyte-derived
Effect of tumor necrosis factor α on MMP9 synthesis by
macrophages on polymerized collagen
Collagen TNFα Experiment 1 Experiment 2
Monomer – 100 100
Polymerized – 9 36
Polymerized + 55 58
Monocytes in suspension for 5 days were seeded onto monomer or poly-
merized collagen with or without 10 ng/mL TNFα with 50 µCi/mL 35S-
methionine for 9 hours. Data are expressed as the percent of the value of
radioimmunoprecipitated MMP9 from cells on monomer collagen.
TNF, Tumor necrosis factor.
Fig 6. Effect of polymerized and monomer collagen on MMP9
synthesis by monocyte/macrophages differentiated in suspension
(method 2) with 10% PDS and M-CSF. After 5 days, cells were
seeded onto thin layers of monomer or polymerized collagen or
maintained in suspension on Hydron for 27 hours with 50
µCi/mL 35S-methionine. MMP9 was radioimmunoprecipitated,
quantitated by means of PhosphorImaging analysis, and
expressed as a percent of the value of Hydron controls (mean ±
SEM; n = 5). *P < .05 versus Hydron.
Fig 7. A, Dose-response study of the effect of PDGF-BB,
PDGF-AA, IL1β, and TNFα on MMP9 synthesis by
macrophages (isolated by means of method 1) cultured on a thick
layer of polymerized collagen. Cells were cultured with 20%
autologous serum for 7 days. During the last 48 hours, test fac-
tors and 35S Methionine were added. Data from PhosphoImager
analysis are expressed as fold of control values (n = 3-6, except for
0.1 ng/mL IL1β and 0.001 ng/mL TNFα, which are n = 2). B,
PDGF-BB, IL1β, and TNFα were given alone and in combina-
tion (all at 10 ng/mL) to cells as described in A. The data are
expressed as fold over control (n = 8). *P < .05 versus control.
A
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macrophages plated on polymerized collagen gels retain a
rounded morphology, as compared with macrophages that
rapidly spread on monomer collagen or plastic. Thus, it is
unclear in our studies whether the rounded morphology,
the distinct signals from polymerized collagen, or both are
responsible for the decrease in MMP9 expression on poly-
merized collagen.
MMP9 expression in macrophages on polymerized
collagen can be upregulated by cytokines and growth
factors. Although the basal level of MMP9 expression is
decreased on polymerized collagen, the secretion of
MMP9 can be increased by stimulation with IL1, TNFα,
and PDGF-BB. Growth factors and cytokines, including
TNFα, IL1β, granulocyte colony stimulating factor, and
M-CSF, can induce MMP9, especially in CD34+
stem/progenitor cells from marrow.34 However, PDGF-
BB has not been demonstrated to regulate MMP9 in
macrophages. PDGF-BB is abundantly expressed in
macrophages in developing lesions and can also be
secreted by smooth muscle cells.35 Expression of the
PDGF-β-receptor36 and PDGF-B chain37 increase with
monocyte-to-macrophage differentiation. In contrast to
macrophages, PDGF-BB has no direct effect on smooth
muscle cell MMP9 synthesis, but augments the stimula-
tory effect of IL1β38 (Kenagy, unpublished). IL1β is
secreted by monocyte/macrophages,39 and PDGF-BB
increases bone-marrow–derived macrophage production
of IL1β,40 suggesting the possibility that IL1β may medi-
ate the effect of PDGF.
MMP9 and lesions of atherosclerosis. The extent
of active synthesis of MMP9 has been strongly correlated
with unstable angina.19 The ability of MMP9 to degrade a
number of extracellular matrix constituents, which are
present in lesions of atherosclerosis and are resistant to
degradation by stromelysin and interstitial collagenases,
may be critical to this correlation.18 The proteolytic activ-
ity of MMP9 is also thought to be necessary for a number
of macrophage functions, including extravasation, migra-
tion, and tissue remodeling during the chronic inflamma-
tory response.7,18 Our data demonstrate that the local
extracellular matrix can significantly alter the secretion of
MMP9 by macrophages and regulate the responsiveness of
macrophages to locally released growth factors and
cytokines.
We thank Muhamed Omer and Shari Wang for tech-
nical assistance.
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